May 14, 2020
Dear All Please see below and attached a press release from BIVDA with a comment from our Chief Executive Doris-Ann Williams, regarding the approval of the COVID-19 antibody test by Public Health England. Kind regards Jon PRESS RELEASE FROM BIVDA FOR IMMEDIATE RELEASE BIVDA Comments on COVID-19 antibody test authorisation by Public Health EnglandBIVDA is delighted to see that an IVD is again making headlines this morning as testing continues to underpin the f...
May 01, 2020
Please see below a short statement from BIVDA Chief Executive Doris-Ann Williams regarding the Government’s meeting of it’s testing target. “I am delighted that the Government has reached its target of 100,000 tests a day. This is a significant achievement by all involved, and I want to congratulate all BIVDA members, officials, health personnel and lab staff who have played a part in making this possible. We are now well on the way to having the infrastructure to s...
Apr 22, 2020
PRESS RELEASE22nd April 2020Stream Bio, a company that develops and manufactures a range of transformative bioimaging molecular probes, is delighted to announce a new joint venture with MIP Diagnostics Ltd., a world leader in molecular imprinting for diagnostic and other applications. The collaborative project will focus on the development of a COVID-19 (or SARS-Cov-2) antigen reagent for assays, a lateral flow Rapid Diagnostic Test (RDT) and an ‘ELISA’ type assay for high throughput...
Apr 03, 2020
Please find below a statement from BIVDA Chief Executive Doris-Ann Williams regarding the new plans to scale up COVID-10 Testing Capacity.Press Statement from Doris-Ann Williams MBE, CEO of BIVDA There has been a great deal of interest this week in the activities of the IVD sector and the role that we can play in scaling up the provision of testing for COVID-19 – for patients, frontline workers and the general public. On Wednesday evening BIVDA participated in a call with the Se...
Apr 02, 2020
Please see attached a joint statement from BIVDA, the ABHI, BIA and ABPI on our commitment to supporting patients and fighting the COVID-19 crisis.
Apr 01, 2020
FOR IMMEDIATE RELEASE "The urgent global need for the components of testing kits and facilities to carry them out is obviously unprecedented, with every country facing challenges to ensure that supply can meet the huge demand from health services. Our companies are working flat out, 24 hours a day, increasing capacity for essential materials to tackle COVID-19 and providing Government and the NHS with additional diagnostics, expertise and facilities so that patients, healthcare w...
Feb 27, 2020
BIVDA PRESS RELEASE - All-Party Parliamentary Group for Life Sciences relaunched to raise profile of the sector On Thursday 27 February, the All-Party Parliamentary Group (APPG) for Life Sciences was relaunched. Chaired by Daniel Zeichner MP, the APPG will raise awareness of UK life sciences among parliamentarians and explore the challenges and opportunities facing the sector. At its first meeting following the General Election, the APPG considered how parliamentarians, government and ...
Feb 03, 2020
London - Monday 3 February 2020The British In Vitro Diagnostic Association comments on Primer Minister's trade speechThe British In Vitro Diagnostic Association (BIVDA) has commented on Boris Johnson’s keynote speech today, in which he set out the British mandate for the forthcoming trade talks with the European Union, and other potential trade deals worldwide. Chief Executive Doris-Ann Williams MBE said;“BIVDA welcome’s the Prime Minister’s intentions to st...
Dec 13, 2019
Commenting on the result of the General Election, BIVDA’s Chief Executive Doris-Ann Williams MBE said:
“BIVDA congratulates the Prime Minister on his return to office and welcomes the increased certainty for business that the General Election result brings.”
May 02, 2019
BIVDA responds to Government’s announcement of new improvements to the Accelerated Access Collaborative and the establishment of a new unit in NHS England and NHS Improvement, led by Dr Sam Roberts as chief executive.